Trial
NCT02442739
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Cedars-Sinai Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Head and Neck Cancer
Intervention
Ketamine
Why stopped
PI voluntary closure due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-06